Pepcid and Zortress drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid (famotidine) and Zortress (everolimus). Common drug interactions include vomiting among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid and Zortress. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.

What is Zortress?

Zortress has active ingredients of everolimus. eHealthMe is studying from 1,589 Zortress users. Check the latest studies of Zortress.



On Aug, 04, 2026

13 people who take Pepcid and Zortress together, and have interactions are studied.

Pepcid and Zortress drug interactions.

What are the common drug interactions of Pepcid and Zortress, by gender? *:

female:

  1. Vomiting
  2. Abdominal pain
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Nausea (feeling of having an urge to vomit)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Acute respiratory failure
  8. Anaemia (lack of blood)
  9. Blood disorder
  10. Cardiac failure congestive

male:

  1. Cough
  2. Insomnia (sleeplessness)
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Concomitant disease progression (progress in accompanying disease)
  5. Dysgeusia (disorder of the sense of taste)
  6. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  7. Left ventricular dysfunction
  8. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  9. Lymphoma (cancer that begins in immune system cells)
  10. Mitral valve incompetence (inefficient heart valve)

What are the common drug interactions of Pepcid and Zortress, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Vomiting
  2. Abdominal pain
  3. Liver disorder (liver diseases)
  4. Back pain
  5. Diarrhoea
  6. Dyspnoea (difficult or laboured respiration)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Disease progression
  3. Drug abuse
  4. Hepatic fibrosis (scarring process that represents the liver's response to injury)
  5. Hepatitis c
  6. Liver transplant rejection (failure of liver transplant)
  7. Peripheral swelling
  8. Swollen tongue (swelling of tongue)

50-59:

  1. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  2. Aortic valve incompetence
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Cough
  5. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  6. Insomnia (sleeplessness)
  7. Left ventricular dysfunction
  8. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  9. Mitral valve incompetence (inefficient heart valve)
  10. Mitral valve stenosis (narrowing of mitral valve)

60+:

  1. Chronic kidney disease
  2. Proteinuria (presence of protein in the urine)
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Frequent bowel movements
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Hypertension (high blood pressure)
  8. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  9. Joint swelling
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Immunodeficiency Disorders: 6 people, 46.15%
  2. Nausea (feeling of having an urge to vomit): 3 people, 23.08%
  3. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 3 people, 23.08%
  4. Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 15.38%
  5. Constipation: 2 people, 15.38%
  6. Urinary Tract Infection: 1 person, 7.69%
  7. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 7.69%
  8. Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
  9. Pain: 1 person, 7.69%
  10. Indigestion: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and Zortress?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid and Zortress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zortress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zortress and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and everolimus (the active ingredients of Pepcid and Zortress, respectively), and Pepcid and Zortress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: